PTGS2 and gastric cancer: This finding demonstrates that COX-2 alone is insufficient for gastric carcinogenesis but acts as a tumor promoter when combined with mutagenic insults, reflecting the multistep nature of human gastric cancer development where COX-2 upregulation typically occurs in the context of chronic inflammation and genetic alterations.